News

Filter

Current filters:

Mylotarg

1 to 9 of 30 results

Wyeth in talks to acquire Crucell; sources say potential offer could be up to $1.35B

12-01-2009

US drug major Wyeth is in early discussions over a potential merger with Dutch vaccine maker Crucell…

EnbreletanerceptGemtuzumab Ozogamicin for InjectionMylotargWyeth

Toricel gets CHMP nod as first-line RCC drug

01-10-2007

The European Medicines Agency's (EMEA) Committee for Medicinal Products for Human Use (CHMP) has issued…

Gemtuzumab Ozogamicin for InjectionMylotargTemsirolimus InjectionToriselWyeth

Wyeth increases stake in Wyeth KK

17-04-2006

USA-based Wyeth says it has purchased an additional 10% stake in Wyeth KK, the joint venture it co-owns…

EnbreletanerceptGemtuzumab Ozogamicin for InjectionMylotargWyeth

Japanese OK for Wyeth's Mylotarg

08-08-2005

Wyeth Japan says that it has obtained approval for Mylotarg, a proprietary preparation of gemtuzumab…

Gemtuzumab Ozogamicin for InjectionMylotargWyeth

Wyeth oncology researchers honored

30-08-2004

Wyeth Pharmaceuticals says that five oncology researchers who led thecompany's development of the first…

Gemtuzumab Ozogamicin for InjectionMylotargWyeth

1 to 9 of 30 results

COMPANY SPOTLIGHT

Menarini

Back to top